EcoDrugPlus

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSPEMG00000006894
Gene Symbol: FGFR3
1 Cross references
196 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSPEMG00000018131
Gene Symbol: FGFR4
3 Cross references
123 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSPEMG00000019000
Gene Symbol: FLT1
3 Cross references
198 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSPEMG00000013317
Gene Symbol: FLT4
3 Cross references
195 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSPEMG00000022051
Gene Symbol: FOLH1B
3 Cross references
210 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSPEMG00000014185
Gene Symbol: FOLR1
3 Cross references
217 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSPEMG00000023546
Gene Symbol: FSHR
1 Cross references
199 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSPEMG00000006951
Gene Symbol: FFAR1
3 Cross references
138 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSPEMG00000018591
Gene Symbol: FFAR2
3 Cross references
331 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSPEMG00000027385
Gene Symbol: FRK
3 Cross references
216 Possible Orthologues:

Galactosidase, Alpha

Ensembl ID : ENSPEMG00000019859
Gene Symbol: GLA
1 Cross references
196 Possible Orthologues:

Gamma-Aminobutyric Acid (Gaba) A Receptor, Subunit Alpha 3

Ensembl ID : ENSPEMG00000018328
Gene Symbol: GABRA3
1 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).